abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

このページは 日本語 では利用できません。English で表示されています

記事

2022年3月3日

著者:
James Doubek, NPR (USA)

Native American tribes reach a tentative opioid settlement with J&J and distributors

The drug manufacturer Johnson & Johnson and the opioid distributors AmerisourceBergen, McKesson and Cardinal Health will pay Native American tribes $590 million under the terms of a proposed settlement filed Tuesday.

The number of deaths from opioid overdoses has been rising across the country, but the problem has been growing disproportionately among Native Americans and Alaska Natives in recent years.

The plaintiffs in the case are more than 400 tribes who say the opioid makers and distributors were responsible for the opioid crisis in their communities and say they've faced increased costs in health care, social services, child care and more as a result.

The proposed agreement between the tribes and Johnson & Johnson and its subsidiary, Janssen, is for $150 million to be paid over two years.

The three distributors: AmerisourceBergen, McKesson and Cardinal Health, agreed to pay roughly $440 million over seven years.

All 574 federally recognized tribes are eligible to receive part of the settlement, even if they did not participate in the litigation, the tribes' lawyers say.

Johnson & Johnson said the proposed settlement is not an admission of liability or wrongdoing and that its marketing and promotion of opioids was "appropriate and responsible." The company says it no longer sells prescription opioids in the U.S.

AmerisourceBergen said the agreement "will both expedite the flow of resources to communities impacted by the crisis while enabling AmerisourceBergen to focus on ensuring the pharmaceutical supply chain is meeting the needs of health care providers and patients."

McKesson and Cardinal Health did not immediately return a request for comment.

The same three drug distributors reached a separate $75 million settlement with the Cherokee Nation in September.

Last summer, state attorneys general announced they had reached a $26 billion settlement with Johnson & Johnson and the three distributors. Johnson & Johnson said its $150 million settlement with the tribes will be taken out of its portion of the settlement with states.

タイムライン

プライバシー情報

このサイトでは、クッキーやその他のウェブストレージ技術を使用しています。お客様は、以下の方法でプライバシーに関する選択肢を設定することができます。変更は直ちに反映されます。

ウェブストレージの使用についての詳細は、当社の データ使用およびクッキーに関するポリシーをご覧ください

Strictly necessary storage

ON
OFF

Necessary storage enables core site functionality. This site cannot function without it, so it can only be disabled by changing settings in your browser.

クッキーのアナリティクス

ON
OFF

When you access our website we use Google Analytics to collect information on your visit. Accepting this cookie will allow us to understand more details about your journey, and improve how we surface information. All analytics information is anonymous and we do not use it to identify you. Google provides a Google Analytics opt-out add on for all popular browsers.

Promotional cookies

ON
OFF

We share news and updates on business and human rights through third party platforms, including social media and search engines. These cookies help us to understand the performance of these promotions.

本サイトにおけるお客様のプライバシーに関する選択

このサイトでは、必要なコア機能を超えてお客様の利便性を高めるために、クッキーやその他のウェブストレージ技術を使用しています。